The Week Ahead: Fed...
Health Care: Drugs
Alexza Pharmaceuticals Inc. (ALXA: NASDAQ)
$0.36 0.00 | -1.37%
06/01/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -40.53M | -1.48M | -56.06M | -58.45M |
| Operating Gains/Losses | 0.00 | 79.00K | 43.00K | -18.57M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -10.00M | 1.41M | -1.41M | 12.06M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | -147.00K | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 822.00K | 76.00K | -2.22M | -278.00K |
| (Decrease) Increase In Other Current Liabilities | -498.00K | 3.92M | -2.72M | -375.00K |
| (Increase) Decrease In Other Working Capital | 3.97M | -1.17M | -11.19M | 677.00K |
| Other Non-Cash Items | 6.41M | 886.00K | 15.11M | 4.33M |
| Net Cash From Continuing Operations | -34.43M | 8.59M | -53.15M | -55.07M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -34.43M | 8.59M | -53.15M | -55.07M |
| Sale of Property, Plant & Equipment | 0.00 | 29.00K | 0.00 | 25.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 54.04M | 41.94M | 34.59M | 92.46M |
| Purchases of Property, Plant & Equipment | -496.00K | -9.18M | -1.19M | -2.73M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -28.46M | -63.43M | -13.26M | -47.11M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 204.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 25.08M | -30.64M | 20.15M | 42.85M |
| Issuance of Debt | 0.00 | 14.81M | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 16.14M | 17.05M | 19.67M | 11.17M |
| Repayment of Long-Term Debt | -5.56M | -2.09M | -4.14M | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | -7.50M | 4.88M | -4.25M |
| Net Cash From Financing Activities | 10.58M | 22.27M | 20.42M | 6.92M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 1.23M | 221.00K | -12.59M | -5.30M |
Portfolios with ALXA
- Portfolio NameUser Type
- Uservlady 1
- ContributorStocks With Big Insider Buy...
- UserSMITTY
- ContributorBarron's Insider Purchases ...
- UserHi Potential
- UserRAPTOR SPRTD RED-03110081643
- UserScottrade 20K
- UserBburn Portfolio 1
- UserRatBastard Portfolio 1
- Userpornholio
Latest ALXA Headlines from TheStreet
- Friday's Top 10 Articles, Videos on TheStreet 05.04.12 | 01:05 pm
- Alexza Stock Gaps Down On Today's Open (ALXA) 05.04.12 | 09:05 am
- Biotech Stock Mailbag: Exelixis, Protalix, Arena 05.04.12 | 07:05 am
- 26 Drugs Facing FDA Approval in 2012 05.02.12 | 01:05 pm
- The Next Big Thing In Biotech: Alexza
04.13.12 | 06:04 am - Alexza Pharmaceuticals Inc. Stock Downgraded (ALXA) 02.24.12 | 05:02 am
- Alexza Stock Gaps Down On Today's Open (ALXA) 02.17.12 | 08:02 am
- 5 Stocks Insiders Are Loading Up On 01.26.12 | 12:01 pm
- Alexza Stock Gaps Up On Today's Open (ALXA) 01.03.12 | 11:01 am
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
Press Releases for ALXA
- Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Alexza Pharmaceuticals Inc. - PR Newswire 05.07.12 | 08:05 am
- Alexza And Grupo Ferrer Amend Adasuve⢠Partnership - PR Newswire 03.07.12 | 04:03 pm
- Alexza To Announce 2011 Year-End Financial Results On Monday, March 12, 2012 - PR Newswire 03.05.12 | 09:03 am
- Alexza Prices $22 Million Public Offering - PR Newswire 02.17.12 | 07:02 am
- Alexza Announces Proposed Public Offering Of Common Stock And Warrants - PR Newswire 02.16.12 | 06:02 pm
- Alexza Pharmaceuticals Receives Day 80 Assessment Report For ADASUVE (Staccato® Loxapine) MAA - PR Newswire 02.13.12 | 08:02 am
- Alexza Retains Lazard To Explore Strategic Options - PR Newswire 12.16.11 | 08:12 pm
- FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval Of Alexza's ADASUVE⢠- PR Newswire 12.13.11 | 05:12 am
- Alexza Pharmaceuticals To Present At The Lazard Capital Markets 8th Annual Healthcare Conference - PR Newswire 11.02.11 | 09:11 am
- Alexza To Announce 2011 Third Quarter Financial Results On Monday, November 7, 2011 - PR Newswire 10.27.11 | 06:10 pm
Partner Headlines for ALXA
- Benzinga's Microcap Movers for Friday May 4, 2012 - Benzinga 05.05.12 | 12:05 pm
- 6 Biotech Stocks With Huge Potential In May - Seeking Alpha 04.11.12 | 08:04 am
- Earnings Expectations for the Week of March 12 (URBN, ROST) - Benzinga 03.11.12 | 11:03 am
- Alexza and Grupo Ferrer Amend Adasuve Partnership Alexza and Grupo Ferrer Amend Adasuve Partnership; Ferrer to Purchase 2.42M Shares of Alexza Common Stock for $1.24 per Share - Benzinga 03.07.12 | 04:03 pm
- Analysis Of Institutional 5% Ownership Filings On Tuesday And Wednesday - Seeking Alpha 01.05.12 | 08:01 am
- Microcap Movers for Friday December 9, 2011 - Benzinga 12.09.11 | 06:12 pm
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Company News for October 5, 2011 - Corporate Summary - Zacks 10.05.11 | 10:10 am
- Alexza Pharmaceuticals Nears Daily High; Ready to Breakout - Benzinga 09.07.11 | 01:09 pm
- Alexza Hopes New NDA Submission Will Relieve Agitation - Benzinga 08.17.11 | 01:08 pm
